Matthew Farrer, PhD, Imperial College
Affiliations: | Neurogenetics and Translational Medicine | University of British Columbia, Vancouver, Vancouver, BC, Canada |
Area:
Neurodegenerative diseasesWebsite:
http://www.cmmt.ubc.ca/research/investigators/farrer/labGoogle:
"Matthew Farrer"Cross-listing: Neurotree
Children
Sign in to add trainee| Emil Karl Gustavsson | grad student | Univesity of British Columia (UBC) (Neurotree) | |
| Igor Tatarnikov | grad student | 2015- | UBC (FlyTree) |
| Stefano Cataldi | grad student | 2014-2018 | UBC (FlyTree) |
| Bahareh Behrouz | post-doc | 2008-2010 | Mayo Clinic Jacksonville (Neurotree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Farrer MJ. (2024) RAB32 mutation in Parkinson's disease - Author's reply. The Lancet. Neurology. 23: 963-964 |
| Guenther DT, Follett J, Amouri R, et al. (2024) The Evolution of Genetic Variability at the Locus. Genes. 15 |
| Deng IB, Follett J, Fox JD, et al. (2024) Characterization of Dnajc12 knockout mice, a model of hypodopaminergia. Biorxiv : the Preprint Server For Biology |
| Domenighetti C, Sugier PE, Ashok Kumar Sreelatha A, et al. (2024) Association of Body Mass Index and Parkinson Disease: A Bidirectional Mendelian Randomization Study. Neurology. 103: e209620 |
| Tan MMX, Lawton MA, Pollard MI, et al. (2024) Genome-wide determinants of mortality and motor progression in Parkinson's disease. Npj Parkinson's Disease. 10: 113 |
| Gopinath A, Ramirez-Zamora A, Franks S, et al. (2024) Immunophenotyping Tracks Motor Progression in Parkinson's Disease Associated with a TH Mutation. Journal of Parkinson's Disease |
| Gustavsson EK, Follett J, Trinh J, et al. (2024) RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses. The Lancet. Neurology |
| Gustavsson EK, Follett J, Trinh J, et al. (2024) A pathogenic variant in RAB32 causes autosomal dominant Parkinson's disease and . Medrxiv : the Preprint Server For Health Sciences |
| Follett J, Guenther D, Xoi L, et al. (2024) Genetic Modifiers of LRRK2 Parkinson's Disease: A Replication Study in Arab-Berbers. Movement Disorders : Official Journal of the Movement Disorder Society |
| Bu M, Follett J, Deng I, et al. (2023) Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice. Npj Parkinson's Disease. 9: 167 |